Charanjit Aulakh

Array ( [id] => 876902 [patent_doc_number] => 07358361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases' [patent_app_type] => utility [patent_app_number] => 11/245612 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13327 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358361.pdf [firstpage_image] =>[orig_patent_app_number] => 11245612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250893 [patent_doc_number] => 07582649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders' [patent_app_type] => utility [patent_app_number] => 11/242654 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45504 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582649.pdf [firstpage_image] =>[orig_patent_app_number] => 11242654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404820 [patent_doc_number] => 07288653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders' [patent_app_type] => utility [patent_app_number] => 11/241805 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9330 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288653.pdf [firstpage_image] =>[orig_patent_app_number] => 11241805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494257 [patent_doc_number] => 07211603 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-01 [patent_title] => 'Enediyne compounds and methods related thereto' [patent_app_type] => utility [patent_app_number] => 11/238231 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 10129 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211603.pdf [firstpage_image] =>[orig_patent_app_number] => 11238231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656609 [patent_doc_number] => 20060142345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => '3,5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation' [patent_app_type] => utility [patent_app_number] => 11/237446 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12414 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142345.pdf [firstpage_image] =>[orig_patent_app_number] => 11237446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606601 [patent_doc_number] => 07153966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Preparation of oxycodone' [patent_app_type] => utility [patent_app_number] => 11/234627 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3326 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153966.pdf [firstpage_image] =>[orig_patent_app_number] => 11234627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291196 [patent_doc_number] => 20090023926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Trityl Derivatives for Enhancing Mass Spectrometry' [patent_app_type] => utility [patent_app_number] => 11/663300 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26301 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023926.pdf [firstpage_image] =>[orig_patent_app_number] => 11663300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806750 [patent_doc_number] => 07419985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => '4-Phenyl substituted tetrahydroisoquinolines and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 11/231398 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25915 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419985.pdf [firstpage_image] =>[orig_patent_app_number] => 11231398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443358 [patent_doc_number] => 07256292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Fluorescent dye compounds, conjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/229012 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12423 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256292.pdf [firstpage_image] =>[orig_patent_app_number] => 11229012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774851 [patent_doc_number] => 08119803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Preparation of opiate analgesics by reductive alkylation' [patent_app_type] => utility [patent_app_number] => 11/628210 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2387 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119803.pdf [firstpage_image] =>[orig_patent_app_number] => 11628210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483307 [patent_doc_number] => 07220757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Compositions and methods for topical administration of 2-NH-heteroarylimidazoles' [patent_app_type] => utility [patent_app_number] => 11/223327 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15289 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220757.pdf [firstpage_image] =>[orig_patent_app_number] => 11223327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880153 [patent_doc_number] => 07354927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => '6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents' [patent_app_type] => utility [patent_app_number] => 11/219940 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16524 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354927.pdf [firstpage_image] =>[orig_patent_app_number] => 11219940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721255 [patent_doc_number] => 20060074030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Cyclopamine analogues and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/213534 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22952 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074030.pdf [firstpage_image] =>[orig_patent_app_number] => 11213534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5904617 [patent_doc_number] => 20060046994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Process for preparing 3-oxo-4-aza-5-alpha-androstane-17-carboxylic acid' [patent_app_type] => utility [patent_app_number] => 11/210528 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2458 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046994.pdf [firstpage_image] =>[orig_patent_app_number] => 11210528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 559434 [patent_doc_number] => 07470703 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-30 [patent_title] => 'Yohimbine derivatives and use thereof' [patent_app_type] => utility [patent_app_number] => 11/210206 [patent_app_country] => US [patent_app_date] => 2005-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 14255 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470703.pdf [firstpage_image] =>[orig_patent_app_number] => 11210206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 363547 [patent_doc_number] => 07482359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/660289 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23826 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482359.pdf [firstpage_image] =>[orig_patent_app_number] => 11660289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596476 [patent_doc_number] => 20100048604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Ligands for Aldoketoreductases' [patent_app_type] => utility [patent_app_number] => 11/660687 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 41777 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048604.pdf [firstpage_image] =>[orig_patent_app_number] => 11660687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867746 [patent_doc_number] => 20080146805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Process for the Production of Levorphanol and Related Compounds' [patent_app_type] => utility [patent_app_number] => 11/632254 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3075 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146805.pdf [firstpage_image] =>[orig_patent_app_number] => 11632254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983603 [patent_doc_number] => 20070088162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Method of preparation of oxycodone' [patent_app_type] => utility [patent_app_number] => 10/569423 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2634 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088162.pdf [firstpage_image] =>[orig_patent_app_number] => 10569423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769369 [patent_doc_number] => 20060019982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/202012 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16342 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019982.pdf [firstpage_image] =>[orig_patent_app_number] => 11202012 [rel_patent_id] =>[rel_patent_doc_number] =>)